Nosocomial pneumonia

Current Opinion in Pulmonary Medicine

Volumn 2, Issue 3, 1996, Pages 206-212

  LeBas, Stuart J ^a   Grier, Laurie R ^a   Campbell Jr , G Douglas ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

BACTERIAL PNEUMONIA; CROSS INFECTION; ECONOMICS; HOSPITAL COST; HUMAN; REVIEW; RISK FACTOR; VIRUS PNEUMONIA;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; HOSPITAL COSTS; HUMANS; PNEUMONIA, BACTERIAL; PNEUMONIA, VIRAL; RISK FACTORS;

EID: 0030132790     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-199605000-00008     Document Type: Article

References (29)

1. Tablan OC, Anderson LJ, Arden NH, Breiman RF, Butler JC, McNeil MM, the Hospital Infection Control Practices Advisory Committee: Guideline for prevention of nosocomial pneumonia. Infect Control Hosp Epidemiol 1994, 15:587-627. Official recommendations for the prevention of hospital-acquired pneumonia from the CDC.
2. Salemi C, Morgan J, Padilla S, Morrissey R: Association between severity of illness and mortality from nosocomial infection. Am J Infect Control 1995, 23:188-193. A retrospective chart review investigating the influence of severity of underlying disease on NP outcome.
3. Gomez J, Esquinas A, Agudo MO, Sanchez Nieto JM, Nunez ML, Banos V, Canteras M, Valdes M: Retrospective analysis of risk factors and prognosis in non-ventilated patients with nosocomial pneumonia. Eur J Clin Microbiol Infect Dis 1995, 14:176-181. A retrospective case-controlled analysis of risk factors for acquiring NP.
4. Craven DE, Steger KA: Epidemiology of nosocomial pneumonia. Chest 1995, 108(suppl 2):1s-16s. A comprehensive review of the incidence, bacteriology, risk factors, and outcomes of NP.
5. Wurtz R, Karajovic M, Dacumos E, Jovanovic B, Hanumandass M: Nosocomial infections in a burn intensive care unit. Burns 1995, 21:181-184.
6. Torres A, Gatell JM, Aznar E, el-Ebiary M, Puig De La Bellacasa J, Gonzales J, Ferrer M, Rodriguez-Roisin R: Re-intubation increases the risk of nosocomial pneumonia in patients needing mechanical ventilation. Am J Respir Crit Care Med 1995, 152:137-141. An examination of increased risk of NP in patients requiring re-intubation. NP was more common among patients requiring re-intubation than among controls. Additionally, a statistically significant difference was noted in total length of ICU stay and mortality between the two groups.
7. Gilmour IJ, Boyle MJ, Streifel A, McComb RC: The effects of circuit and humidifier type on contamination potential during mechanical ventilation; a laboratory study. Am J Infect Control 1995, 23:65-72.
8. Dreyfuss D, Djedaini K, Gros I, Mier L, Le Bourdelles G. Cohen Y, Estagnasie P, Coste F, Boussougant Y: Mechanical ventilation with heated humidifiers or heat and moisture exchangers: effects on patient colonization and incidence of nosocomial pneumonia. Am J Respir Crit Care Med 1995, 151:986-992.
9. Kollef MH, Shapiro SD, Fraser VJ, Silver P, Murphy DM, Trovillion E, Hearns ML, Richards RD, Cracchilo L, Hossin L: Mechanical ventilation with or without 7-day circuit changes. Ann Intern Med 1995, 123:168-174. A randomized, controlled comparison of a 7-day circuit change versus no circuit change performed in a large number of patients. Findings are well supported and show little difference in the incidence of hospital mortality. The authors suggest elimination of routine circuit changes as a cost-saving measure.
10. Bert F, Lambert-Zechovsky N: Pneumonia associated with nosocomial sinusitis: a different risk according to the pathogen involved. Am J Respir Crit Care Med 1995, 152:1424-1425.
11. Rouby JJ, Laurent P, Gosnach M, Cambau E, Lamas G, Zoulaoui A, Leguillou JL, Bodin L, Do Khac T, Marsault C, et al.: Risk factors and clinical relevance of nosocomial maxillary sinusitis in the critically ill. Am J Respir Crit Care Med 1994, 150:776-783.
12. Rouby JJ: Pneumonia associated with nosocomial sinusitis: a different risk according to the pathogen involved [letter]. Am J Respir Crit Care Med 1995, 150:1425.
13. Valles J, Artigas A, Rello J, Bonsoms N, Fontanals D, Blanch L, Fernandez R, Baigorri F, Mestre J: Continuous aspiration of subglottic secretions in preventing ventilator associated pneumonia. Ann Intern Med 1995, 122:179-186. Continuous aspiration of subglottic secretions reduced the rate of VAP compared with that in controls, but this reduction was associated primarily with a reduction in the incidence of early VAP and a reduction in VAP due to H. influenzae and gram-positive coccal infections, but not VAP due to P. aeruginosa and Enterobacter spp.
14. Bonten MJM, Gaillard CA, Johanson WG Jr., Van Tiel FH, Smeets HGW, Van Der Geest S, Stobberingh EE: Colonization of patients receiving and not receiving topical antimicrobial prophylaxis. Am J Respir Crit Care Med 1994, 150:1332-40. Topical antimicrobial prophylaxis reduced the colonization rate for Enterobacteriaceae spp., Pseudomonas spp., and Xanthomonas spp. both in treated patients and in control, nontreated, patients residing in the same ICU, but not in control patients residing in a distant ICU.
15. Wiener J, Karajovic M, Dacumos E, Jovanovic B, Hanumadass M: A randomized, double-blind, placebo-controlled trial of selective decontamination in a medical-surgical intensive care unit. Clin Infect Dis 1995, 20:861-867.
16. Mody CH, Buser DE, Syme RM, Woods DE: Pseudomonas aeruginosa exoenzyme S induces proliferation of human T lymphocytes. Infect Immun 1995, 63:1800-1885.
17. Raoof S, Grant MM, Niederman MS, Poehlman MA, Matin AF, Kahn FA, Fein AM: Cytokines affect pseudomonas binding to tracheal cells via a neutrophil-mediated process. Am J Respir Crit Care Med 1995, 152:921-926.
18. Dipiro JT, Howdieshell TR, Goddard JK, Callaway DB, Hamilton RG, Mansberger AR Jr: Association of interleukin-4 plasma levels with traumatic injury and clinical course. Arch Surg 1995, 130:1159-1163.
19. Timsit JF, Misset B, Renaud B, Goldstein FW, Cartel J: Effect of previous antimicrobial therapy on the accuracy of the main procedures used to diagnose nosocomial pneumonia in patients who are using ventilation. Chest 1995, 108:1036-1040.
20. Niederman MS: An approach to empiric therapy of nosocomial pneumonia. Med Clin North Am 1994, 78:1123-1141.
21. Taylor GD, Buchanan-Chell M, Kirkland T, McKenzie M, Wiens R: Bacteremic nosocomial pneumonia: a 7-year experience in one institution. Chest 1995, 108:786-876.
22. Holladay RC, Campbell GD Jr: Nosocomial viral pneumonia in the intensive care unit. Clin Chest Med 1995, 16:121-133.
23. Pallares R, Linares J, Vadilla M, Cabellos C, Manresa F, Viladrich PF, Martin R, Gudiol F: Resistance to penicillin and cephalosporins and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995, 333:474-80. A 10-year study evaluating the incidence and outcome from PRP infections. The incidence of PRP infections increased dramatically during this time period, but outcome between patients with PRP and those with pneumococci sensitive to penicillin was not significantly different when outcome was adjusted for other predictors.
24. Mandigers CMPW, Diespersloot RJA, Dessens M, Mol SJM, van Klingeren B: A hospital outbreak of penicillin-resistant Pneumococci in the Netherlands. Eur Respir J 1994, 7:1635-1639.
25. Yigla M, Finkelstein R, Hashman N, Green P, Cohn L, Merzbach D: Epidemiology and clinical spectrum of pneumococcal infections: an Israeli viewpoint J Hosp Infect 1995, 29:57-64.
26. Luck PC, Helbig JH, Hagedorn HJ, Ehret W: DNA fingerprinting by pulsed-field gel electrophoresis to Investigate a nosocomial pneumonia caused by Legionella bozemanii serogroup 1. Appl Environ Microbiol 1995, 61:2759-2761.
27. Kerr JR, Moore JE, Curran MD, Graham R, Webb CH, Lowry K, Murphy G, Wilson TS, Ferguson WP: Investigation of a nosocomial outbreak of Pseudomonas aeruginosa pneumonia in an intensive care unit by random amplification of polymorphic DNA assay. J Hosp Infect 1995, 30:125-131.
28. Bergogne-Berezin E: The Increasing significance of outbreaks of Acinetobacter spp.: the need for control and new agents. J Hosp Infect 1995, 30(suppl):441-452.
29. Bergogne-Berezin E: Treatment and prevention of nosocomial pneumonia. Chest 1995, 108:26s-34s. This review of pathogens causing NP discusses strategies for antibiotic therapy, including newer antibiotic approaches. A brief focus on NP prevention is also included.